Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of ...
The Broward school district cites an exemption for collective bargaining strategies in the state’s open-meeting law, although the issue wasn’t actually bargained.
For the best results, medications like Ozempic and Zepbound should be combined with exercise and healthy eating habits.
Texas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical giant Sanofi, accusing the company of unlawfully ...
Eli Lilly and Company (NYSE: LLY) is one of the best growth stocks to buy for the next 20 years. On February 18, Eli Lilly ...
The results of 2 recent clinical trials combining the GLP-1 drug and the biologic reinforce the benefits of treating obesity ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...
Combination ixekizumab plus tirzepatide outperformed ixekizumab monotherapy for the treatment of both psoriasis and ...
Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.
Everyone has been talking about Ozempic in recent years. You may have seen the name in the news or even know someone who is ...
With insurance plans dropping coverage of the drugs, those of us benefiting from them face a costly decision — beyond just ...
Eli Lilly's latest trial results and new licensing agreement show promise in treating psoriasis, obesity, and kidney disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results